One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings<br />(The SPIRIT FIRST Trial)
EuroInterv.2005;1:266-272.
Keiichi Tsuchida1, MD, PhD; Jan J. Piek2, MD, PhD; Franz-Josef Neumann3, MD; Willem J. van der Giessen1, MD, PhD; Marcus Wiemer4, MD; Andreas M. Zeiher5, MD; Eberhard Grube6, MD; Jürgen Haase7, MD, PhD; Leif Thuesen8, MD; Christian W. Hamm9, MD; Susan Veldhof10, RN; Cécile Dorange10, MSc; Patrick W. Serruys1*, MD, PhD
1. Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands. 2. Academisch Medisch Centrum, Amsterdam, The Netherlands. 3. Herz-zentrum Bad Krozingen, Bad Krozingen, Germany. 4. Herz- und Diabeteszentrum Nordrhein-Westfalen der Rhur-Univasität Boc
Aim: Short-term results of durable polymer everolimus-eluting stents have shown significant improvements in clinical and angiographic outcomes. This report presents the 1-year clinical and angiographic data from